CRIS Current Research Information System

GALLINELLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.136
EU - Europa 5.099
AS - Asia 2.893
AF - Africa 325
SA - Sud America 82
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.106
GB - Regno Unito 1.303
IT - Italia 1.121
CN - Cina 987
VN - Vietnam 774
SG - Singapore 636
DE - Germania 606
SE - Svezia 486
UA - Ucraina 360
RU - Federazione Russa 311
IN - India 290
IE - Irlanda 198
FR - Francia 192
CH - Svizzera 131
EE - Estonia 109
ZA - Sudafrica 105
TG - Togo 85
BG - Bulgaria 73
NL - Olanda 41
CI - Costa d'Avorio 40
JO - Giordania 39
AR - Argentina 38
NG - Nigeria 37
FI - Finlandia 36
IR - Iran 35
BE - Belgio 32
BR - Brasile 32
AT - Austria 30
IQ - Iraq 30
SC - Seychelles 29
CA - Canada 24
JP - Giappone 22
HK - Hong Kong 18
ID - Indonesia 15
KE - Kenya 12
PL - Polonia 12
PK - Pakistan 11
ES - Italia 10
GR - Grecia 9
RO - Romania 9
CM - Camerun 8
LT - Lituania 7
UZ - Uzbekistan 7
LB - Libano 6
PE - Perù 6
CZ - Repubblica Ceca 5
HR - Croazia 5
TH - Thailandia 5
AU - Australia 4
CL - Cile 4
HU - Ungheria 4
SA - Arabia Saudita 4
TR - Turchia 4
RS - Serbia 3
TW - Taiwan 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
MX - Messico 2
NO - Norvegia 2
SN - Senegal 2
TD - Ciad 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 14.543
Salva come PNG Salva come JPEG
Città #
Southend 1.166
Fairfield 673
Ashburn 600
Chandler 589
Dong Ket 514
Singapore 508
Seattle 339
Wilmington 325
Woodbridge 318
Princeton 277
Houston 250
Jacksonville 246
Bologna 236
Ann Arbor 231
Cambridge 226
Dublin 198
Santa Clara 193
Boardman 173
Padova 129
Westminster 127
Bern 121
Nanjing 116
Berlin 93
Lomé 85
Milan 83
Sofia 72
New York 71
Medford 70
Jinan 64
Saint Petersburg 63
Shenyang 59
Changsha 47
Hebei 46
Mülheim 46
Abidjan 40
Amman 39
Nanchang 38
Abeokuta 37
Beijing 37
Florence 36
San Diego 35
Helsinki 34
Tianjin 34
Zhengzhou 34
Buenos Aires 32
Rome 32
Bremen 31
Redwood City 31
Brussels 30
Shanghai 29
Fremont 28
Mahé 27
Dearborn 24
Hangzhou 24
Jiaxing 24
Verona 23
Yubileyny 23
Ningbo 20
Olalla 20
Pune 20
Tokyo 20
Des Moines 19
Guangzhou 18
Los Angeles 18
Taizhou 18
Vienna 18
Toronto 17
Modena 15
Phoenix 15
Taiyuan 15
Mountain View 14
Redmond 14
Fuzhou 13
Hong Kong 13
Norwalk 13
Tappahannock 13
Turin 13
Falkenstein 12
Falls Church 12
Kunming 12
Nairobi 12
Shenzhen 12
Wuhan 12
Jakarta 11
Shijiazhuang 11
Haikou 10
Kirkuk 10
London 10
Paris 10
Ravenna 10
San Venanzo 10
Montegaldella 9
Nuremberg 9
Tavagnacco 9
Baghdad 8
Bühl 8
Hyderabad 8
Lanzhou 8
Leawood 8
Monmouth Junction 8
Totale 9.631
Salva come PNG Salva come JPEG
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 214
Antiviral activity of brincidofovir on parvovirus B19 201
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 188
The clinical use of parvovirus B19 assays: recent advances 158
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 158
Antiviral effect of cidofovir on parvovirus B19 replication 157
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 156
Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19 154
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 153
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 151
A proteomic approach to the analysis of B19 capsid proteins 148
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 145
A portable Microfluidic Device Based on Chemiluminescence Contact Imaging for detecting Parvovirus B19 in serum samples 145
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 144
Advances in the development of antiviral strategies against parvovirus B19 144
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 143
Parvovirus B19 Achievements and Challenges 142
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 141
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 140
Detection of viral DNA by isothermal NASBA amplification and chemiluminescence gene probe hybridization assay in a microfluidic cartridge 140
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 138
A Parvovirus B19 synthetic genome: sequence features and functional competence 138
Analisi della competenza funzionale di cloni genomici di parvovirus B19 135
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 134
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 133
On-chip LAMP-BART reaction for viral DNA real-time bioluminescence detection 133
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 130
null 127
Recurrent erythema in patients with long-term parvovirus B19 infection 125
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 125
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 125
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 125
A Functional Minigenome of Parvovirus B19 125
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 124
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 124
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 123
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 123
A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells 122
Simian parvovirus infection: a potential zoonosis 121
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 121
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 120
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 120
How does parvovirus B19 DNA achieve lifelong persistence in human cells? 120
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 119
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 118
Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells 118
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 117
Antiviral effect of Hydroxyurea on B19V replication 117
Portable chemiluminescence multiplex biosensor for quantitative detection of three B19 DNA genotypes 117
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 116
A loop-mediated isothermal amplification (LAMP) assay to detect parvovirus B19 DNA in clinical samples 116
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 115
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 115
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 115
Analysis at single cell level of parvovirus B19 expression process by chemiluminescent microscope imaging assays 114
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells 114
Evidence of human bocavirus viremia in healthy blood donors. 112
Analysis of the functional competence of genomic clones of Parvovirus B19 112
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays 111
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 110
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells 110
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 109
Single-cell chemiluminescence imaging of parvovirus B19 life cycle 108
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones 107
Microfluidic cartridge with integrated array of amorphous silicon photosensors for chemiluminescence detection of viral DNA 107
Mesenchymal stem cells are susceptible but non-permissive to B19V replication 107
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 106
Analysis on Parvovirus B19 life cycle at single cell level by chemiluminescent imaging assays 106
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 106
Antiviral effect of Cidofovir on B19V replication 105
Parvovirus B19 DNA detection in serum samples employing a microfluidic device based on chemiluminescence contact imaging. 104
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 103
Tecniche di amplificazione real-time nella determinazione della carica virale: parvovirus B19 e papillomavirus umani 102
Parvovirus B19-derived fetal complications following gestational infection. 102
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 102
Placental endothelial cells can be productively infected by Parvovirus B19 102
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 101
No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions 101
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 99
null 99
Parvoviridae 99
Cellule progenitrici eritroidi ottenute da sangue periferico come sistema per lo studio della replicazione ed espressione di B19V 97
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 92
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 92
Implicazioni nella progressione della patologia cervicale 91
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 91
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: Increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. 91
Cidofovir exerts an inhibitory effect on Parvovirus B19 replication 91
Detection of parvovirus B19 IgG: choice of antigens and serological tests 90
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 89
Gastrointestinal lesions in parvovirus B19 infection 87
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 87
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 86
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 85
null 85
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 84
Molecular Testing for Parvoviruses 84
Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells 84
Restriction Factors expression decreases in HIV-1 patients after cART 84
Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity 83
Totale 11.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020436 0 0 0 0 0 0 0 0 0 188 97 151
2020/20212.161 390 92 89 97 46 107 37 87 175 108 88 845
2021/20222.442 232 124 119 193 205 126 55 169 89 197 492 441
2022/20232.561 282 345 128 316 157 168 77 122 423 50 232 261
2023/20241.222 46 127 75 147 101 252 84 94 56 70 83 87
2024/20252.233 152 490 320 233 420 173 282 100 62 1 0 0
Totale 14.933